B cells in multiple sclerosis: connecting the dots
- 31 December 2011
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 23 (6), 713-720
- https://doi.org/10.1016/j.coi.2011.09.003
Abstract
No abstract availableKeywords
Funding Information
- Pfizer Pharmaceuticals
This publication has 60 references indexed in Scilit:
- Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulinJournal of Neuroimmunology, 2011
- B‐cell activation influences T‐cell polarization and outcome of anti‐CD20 B‐cell depletion in central nervous system autoimmunityAnnals of Neurology, 2010
- Memory B cells from a subset of treatment‐naïve relapsing‐remitting multiple sclerosis patients elicit CD4+ T‐cell proliferation and IFN‐γ production in response to myelin basic protein and myelin oligodendrocyte glycoproteinEuropean Journal of Immunology, 2010
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in miceBrain, 2010
- Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluidAnnals of Neurology, 2009
- Neurofascin as a novel target for autoantibody-mediated axonal injuryThe Journal of Experimental Medicine, 2007
- Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MSJournal of Neuroimmunology, 2007
- Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosisProceedings of the National Academy of Sciences of the United States of America, 2006
- Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patientsJournal of Neuroimmunology, 2006
- Persistent expression of autoantibodies in SLE patients in remissionThe Journal of Experimental Medicine, 2006